Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
Kyla-Louise Wood, Daniel J. Myall, Leslie Livingston, et al.
npj Parkinson s Disease (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Cognitive decline in Parkinson disease
Dag Aarsland, Byron Creese, Marios Politis, et al.
Nature Reviews Neurology (2017) Vol. 13, Iss. 4, pp. 217-231
Open Access | Times Cited: 843
Parkinson disease-associated cognitive impairment
Dag Aarsland, Lucia Batzu, Glenda M. Halliday, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 748
Cognitive decline in Parkinson’s disease: the complex picture
Roberta Biundo, Luca Weis, Angelo Antonini
npj Parkinson s Disease (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 124
Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis
Dimitrios Saredakis, Lyndsey E. Collins‐Praino, Daria S. Gutteridge, et al.
Parkinsonism & Related Disorders (2019) Vol. 65, pp. 20-31
Closed Access | Times Cited: 108
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
Bastiaan R. Bloem, William J. Marks, Ana Lígia Silva de Lima, et al.
BMC Neurology (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 101
The role of GPCRs in neurodegenerative diseases: avenues for therapeutic intervention
Yunhong Huang, Nicholas Todd, Amantha Thathiah
Current Opinion in Pharmacology (2017) Vol. 32, pp. 96-110
Closed Access | Times Cited: 93
Parkinson disease-associated cognitive impairment

Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 75
Extracellular vesicle biomarkers for cognitive impairment in Parkinson’s disease
Joseph Blommer, Toni L. Pitcher, Maja Mustapić, et al.
Brain (2022) Vol. 146, Iss. 1, pp. 195-208
Open Access | Times Cited: 63
Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
Tracy R. Melzer, Megan Stark, Ross Keenan, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 65
Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment
Seok Jong Chung, Han Soo Yoo, Yang Hyun Lee, et al.
Human Brain Mapping (2019) Vol. 40, Iss. 13, pp. 3784-3794
Open Access | Times Cited: 54
Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests
Jeroen Hoogland, Lennard L. van Wanrooij, Judith A. Boel, et al.
Movement Disorders (2018) Vol. 33, Iss. 11, pp. 1750-1759
Open Access | Times Cited: 55
Cognitive impairment in Parkinson's disease: impact on quality of life of carers
Rachael A. Lawson, Alison J. Yarnall, Fionnuala Johnston, et al.
International Journal of Geriatric Psychiatry (2016) Vol. 32, Iss. 12, pp. 1362-1370
Open Access | Times Cited: 54
Risk of Parkinson's disease dementia related to level I MDS PD‐MCI
Jeroen Hoogland, Judith A. Boel, Rob M.A. de Bie, et al.
Movement Disorders (2019) Vol. 34, Iss. 3, pp. 430-435
Closed Access | Times Cited: 45
Morphological basis of Parkinson disease-associated cognitive impairment: an update
K. A. Jellinger
Journal of Neural Transmission (2022) Vol. 129, Iss. 8, pp. 977-999
Closed Access | Times Cited: 26
White Matter Microstructural Underpinnings of Mild Behavioral Impairment in Parkinson's Disease
Oury Monchi, Gabriel David Pinilla-Monsalve, Hannes Almgren, et al.
Movement Disorders (2024) Vol. 39, Iss. 6, pp. 1026-1036
Open Access | Times Cited: 4
Early‐phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease
William Aye, Megan Stark, Kyla‐Louise Horne, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2024) Vol. 16, Iss. 2
Open Access | Times Cited: 4
A study on the exploration of mild cognitive impairment in Parkinson’s disease based on decision-making cognitive computing
Shouqiang Huang, Kai Li, Chen Wang, et al.
Frontiers in Neuroscience (2025) Vol. 18
Open Access
Single- versus two-test criteria for cognitive impairment: associations with CSF and imaging markers in former American football players
Monica T. Ly, Caroline Altaras, Yorghos Tripodis, et al.
The Clinical Neuropsychologist (2025), pp. 1-25
Closed Access
A network perspective on cognition in individuals with Parkinson's disease
Daniel Scharfenberg, Elke Kalbe, Monika Balzer‐Geldsetzer, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2025) Vol. 17, Iss. 1
Open Access
Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort
Jacob D. Jones, Taylor Kuhn, Sarah M. Szymkowicz
Parkinsonism & Related Disorders (2017) Vol. 47, pp. 3-7
Open Access | Times Cited: 47
Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI)
Ann Judith Jones, Roeline G. Kuijer, Leslie Livingston, et al.
Translational Neurodegeneration (2017) Vol. 6, Iss. 1
Open Access | Times Cited: 45
Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in 18F‐FDG PET imaging
Lei Wu, Fengtao Liu, Jingjie Ge, et al.
Human Brain Mapping (2018) Vol. 39, Iss. 12, pp. 4652-4662
Open Access | Times Cited: 43
Parkinson’s Disease–Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update Knowledge
Davide Maria Cammisuli, Salvatore Massimiliano Cammisuli, Jonathan Fusi, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 37
The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease
Hailing Liu, Bin Deng, Fen Xie, et al.
Annals of Clinical and Translational Neurology (2021) Vol. 8, Iss. 9, pp. 1917-1934
Open Access | Times Cited: 29
Phase lag index and spectral power as QEEG features for identification of patients with mild cognitive impairment in Parkinson's disease
Menorca Chaturvedi, J.G. Bogaarts, Vitalii V. Kozak, et al.
Clinical Neurophysiology (2019) Vol. 130, Iss. 10, pp. 1937-1944
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top